Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascentage Pharma Group International's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.47.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascentage Pharma Group International's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.05.
Ascentage Pharma Group International (OTCPK:ASPHF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ascentage Pharma Group International's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ascentage Pharma Group International's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ascentage Pharma Group International Days Inventory Related Terms
Ascentage Pharma Group International Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International Days Inventory Chart
ASPHF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Ascentage Pharma Group International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascentage Pharma Group International Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ascentage Pharma Group International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascentage Pharma Group International (ASPHF) has a Days Inventory of 123.87 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascentage Pharma Group International and its competitors. This is 15% below median its historical median of 145.31. Over the past decade, Ascentage Pharma Group International's Days Inventory has ranged from 108.64 to 431.01. According to the industry distribution chart, Ascentage Pharma Group International ranks #191 out of 635 companies in the Biotechnology industry, placing it in the top 30.1%.
Is Ascentage Pharma Group International's Days Inventory too high?
Ascentage Pharma Group International's current Days Inventory of 123.87 is 15% below median its 10-year median of 145.31. Over the past 10 years, this metric has ranged from a low of 108.64 to a high of 431.01. The Biotechnology industry median Days Inventory is 183.23. Ascentage Pharma Group International's value of 123.87 is 32.4% below this industry median. Based on the distribution chart, Ascentage Pharma Group International ranks #191 out of 635 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Ascentage Pharma Group International has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ascentage Pharma Group International's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ascentage Pharma Group International ranks #191 out of 635 companies for Days Inventory. This puts Ascentage Pharma Group International in the upper half of its industry. The industry median Days Inventory is 183.23. Ascentage Pharma Group International's value of 123.87 is 32.4% below this benchmark. Historically, Ascentage Pharma Group International's own Days Inventory has ranged from 108.64 to 431.01 over the past decade. While the company's 10-year median is 145.31 vs. the industry median of 183.23, Ascentage Pharma Group International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascentage Pharma Group International's current Days Inventory of 123.87 is 32.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ascentage Pharma Group International and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascentage Pharma Group International's current Days Inventory is 123.87, which is 15% below median its own 10-year median of 145.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascentage Pharma Group International stock overvalued right now?
Based on GuruFocus' analysis, Ascentage Pharma Group International (ASPHF) is currently considered Possible Value Trap. The stock's GF Value™ is $7.38, compared to a current price of $4.53 — trading 38.6% below its estimated fair value. The current Days Inventory is 123.87, which is 15% below median its 10-year median of 145.31 and 32.4% below the Biotechnology industry median of 183.23. Ascentage Pharma Group International's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ascentage Pharma Group International (ASPHF), the current Days Inventory is 123.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ascentage Pharma Group International (ASPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Ascentage Pharma Group International stock appears to be undervalued.
The current stock price of $4.53 is trading 38.6% below its estimated GF Value™ of $7.38.
GuruFocus considers Ascentage Pharma Group International to be Possible Value Trap.
Key valuation signals for ASPHF:
Days Inventory: 123.87 (15% below median its 10-year median of 145.31)
GF Value™: $7.38 vs. price of $4.53 (38.6% below fair value)
Industry Position: 32.4% below the Biotechnology median (#191 of 635)
No single metric tells the full story. See the ASPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ascentage Pharma Group International Business Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
66GF Score
Get the complete analysis for ASPHF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPHF has been successfully added to your 
